(Q53803614)

19 May 2018

title

Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia. (English)

1 reference

19 May 2018

glucocorticoid resistance

1 reference

1 reference

R Marke

1

1 reference

19 May 2018

J Havinga

2

1 reference

19 May 2018

J Cloos

3

1 reference

19 May 2018

M Demkes

4

1 reference

19 May 2018

G Poelmans

5

1 reference

19 May 2018

L Yuniati

6

1 reference

19 May 2018

D van Ingen Schenau

7

1 reference

19 May 2018

E Sonneveld

8

1 reference

19 May 2018

E Waanders

9

1 reference

19 May 2018

R Pieters

10

1 reference

19 May 2018

R P Kuiper

11

1 reference

19 May 2018

P M Hoogerbrugge

12

1 reference

19 May 2018

G J L Kaspers

13

1 reference

19 May 2018

F N van Leeuwen

14

1 reference

19 May 2018

B Scheijen

15

1 reference

19 May 2018

publication date

29 December 2015

1 reference

19 May 2018

published in

Leukemia

1 reference

19 May 2018

volume

30

1 reference

19 May 2018

issue

7

1 reference

19 May 2018

page(s)

1599-1603

1 reference

19 May 2018

Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.359

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.359

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.359

Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.359

Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.359

Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.359

NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.359

Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.359

CREBBP mutations in relapsed acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.359

Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.359

Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.359

Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.359

Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26713593

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26713593

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26713593

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/LEU.2015.359

1 reference

19 May 2018

1 reference

19 May 2018